Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

September 2023

Propriétés différentielles des inhibiteurs de Janus Kinase dans le traitement des maladies inflammatoires à médiation immunitaire

Rheumatology (Oxford) 2023;63(2):298–308 doi 10.1093/rheumatology/kead448

Choy E,

Lippe R,

JAKis differ in structure, which affects their inhibitory concentration for different JAKs.

This review by Taylor, et al. compares the pharmacological profiles of JAKis, including abrocitinib, baricitinib, filgotinib, peficitinib, tofacitinib, and upadacitinib.

Keywords:

February 2023

Infections opportunistes associées au traitement de la polyarthrite rhumatoïde par les inhibiteurs de Janus Kinase : Une revue structurée de la littérature

Semin Arthritis Rheum. 2023;58:152120

Desai S,

Barry J,

Strengholt S,

Galloway J

Structured literature review shows a varied incidence of opportunistic infections (OIs) among RA patients exposed to JAK inhibitors.